Quebec Launches $21M Personalized Medicine Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Quebec's government will provide C$10 million (US$9.9 million) over four years to launch a new personalized cancer medicine collaboration between private and public partners that will aim to integrate biomarkers into cancer care and reduce treatment costs.

The new Personalized Medicine Partnership for Cancer also will raise C$11.1 million from private-sector partners, and it will be led by the Montreal-based protein biomarker developer Caprion Proteome, according to the partners in the effort.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.